Financials
- Fiscal year
- 2025
- Total assets
- €29,309
- Profit
- €14,824
- Solvency
- 60.8%
InEssence Studio
ActiveSummary
InEssence Studio is younger than twelve months; there is no public track record yet to compute a bankruptcy probability from. The 2025 annual accounts show equity of €17,824 and a net result of €14,824. Its solvency ranks better than 73% of 22044 sector peers (fiscal year 2025). The company has been active since 2025 and the Belgian State Gazette contains no insolvency or warning signals.
Overview
Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€29,309total assets 2025
- Equity
- €17,824
- Profit
- €14,824
Turnover not published (abridged schema)
Structure
- Board
- 1 member
Accounts 32 d early
Why 89- Young companyLatest accounts filed on timeShow the evidence
Checked score
Score 2025
89
/ 100
Excellent
Without a bankruptcy probability: score from the figures alone
Financial strength
Strong
Solvency
86
equity 60.8% of total assets
Liquidity
82
short-term debt 39.2% · cash 59.3%
Profitability
100
return on assets 50.6%
Bankruptcy probability, 12 months
This company is younger than 12 months. There is no public track record yet to base a reliable estimate on, so we'd rather not show a number.
Credit up to €1,500 at 30 days acceptable
Liquidity ample (current ratio 2.55; short-term debt: 39.2% and cash: 59.3% of total assets), and 39.2% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Two signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Young company
Founded in 2025, under 3 years in business. Failure risk is statistically highest between 2 and 8 years after founding.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-06-2026, 32 days ahead of the deadline.
NBB · 1 filingDeviation from the deadline
2025
32 d early
← before the deadline
after the deadline →
Checked, nothing found (1)
- Annual accounts filedfiscal year 2025 · micro…
- IncorporationAppointment: Sarah RUBENS (non-statutory director)…
Key points
By topic
Board & ownership
- Board
- 1 member
Go to Board & ownership
Timeline
- Events
- 2
- Since
- 2025
- 29-06-2026Annual accounts filed
- 10-12-2025Incorporation
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Founded
- 08-12-2025
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Articles of association
- Provisions read
- 29
- Annual meeting
- Last Thursday of June at 18:00
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark Roughly what is this company worth?Value indication
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.